Literature DB >> 9609997

High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families.

T Katagiri1, F Kasumi, M Yoshimoto, T Nomizu, K Asaishi, R Abe, A Tsuchiya, M Sugano, S Takai, M Yoneda, T Fukutomi, K Nanba, M Makita, H Okazaki, K Hirata, M Okazaki, Y Furutsuma, Y Morishita, Y Iino, T Karino, H Ayabe, S Hara, T Kajiwara, S Houga, Y Miki.   

Abstract

Mutations in either of two recently identified genes, BRCA1 and BRCA2, are thought to be responsible for approximately two-thirds of all cases of autosomal-dominantly inherited breast cancer. To examine the nature and frequency of BRCA1 and BRCA2 mutations in Japanese families exhibiting a high incidence of breast cancer, we screened 78 unrelated families in this category for mutations of these two genes. Examining the entire coding sequences as well as exon-intron boundaries of both genes by polymerase chain reaction (PCR) single-strand conformation polymorphism (SSCP) and multiplex-SSCP analysis, we identified possible disease-causing alterations in BRCA1 among affected members of 15 families and in BRCA2 in another 14 families. In 15 of those 29 families, the affected individuals carried missense mutations, although most germline mutations reported worldwide have been deletions or nonsense mutations. Our results, indicating that missense mutations of BRCA1 and BRCA2 tend to predominate over frameshifts or nonsense mutations in Japanese breast cancer families, will contribute significantly to an understanding of mammary tumorigenesis in Japan, and will be of vital importance for future genetic testing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9609997     DOI: 10.1007/s100380050035

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  9 in total

1.  High proportion of novel mutations of BRCA1 and BRCA2 in breast/ovarian cancer patients from Castilla-León (central Spain).

Authors:  Mar Infante; Mercedes Durán; Eva Esteban-Cardeñosa; Cristina Miner; Eladio Velasco
Journal:  J Hum Genet       Date:  2006-06-07       Impact factor: 3.172

2.  A misquoted mutation in exon16 of the BRCA2 gene.

Authors:  Agapi Kataki; Anastasia Derventzi; Ilias Gomatos; Manoussos M Konstadoulakis
Journal:  J Hum Genet       Date:  2006-01-25       Impact factor: 3.172

3.  Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory.

Authors:  William Gradishar; KariAnne Johnson; Krystal Brown; Erin Mundt; Susan Manley
Journal:  Oncologist       Date:  2017-04-13

4.  Application of ACMG criteria to classify variants in the human gene mutation database.

Authors:  Hui-Qi Qu; Xiang Wang; Lifeng Tian; Hakon Hakonarson
Journal:  J Hum Genet       Date:  2019-08-26       Impact factor: 3.172

5.  BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients.

Authors:  Myong Cheol Lim; Sokbom Kang; Sang-Soo Seo; Sun-Young Kong; Bo-Yon Lee; Seon-Kyung Lee; Sang-Yoon Park
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-05       Impact factor: 4.553

6.  Characterization of BRCA1 ring finger variants of uncertain significance.

Authors:  Kevin Sweet; Leigha Senter; Robert Pilarski; Lai Wei; Amanda Ewart Toland
Journal:  Breast Cancer Res Treat       Date:  2009-06-20       Impact factor: 4.872

7.  Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.

Authors:  Ava Kwong; Enders Kai On Ng; Chris Lei Po Wong; Fian Bic Fai Law; Tommy Au; Hong Nei Wong; Allison W Kurian; Dee W West; James M Ford; Edmond Siu Kwan Ma
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

Review 8.  Characterization of potential driver mutations involved in human breast cancer by computational approaches.

Authors:  Barani Kumar Rajendran; Chu-Xia Deng
Journal:  Oncotarget       Date:  2017-07-25

9.  A new bioinformatics tool to help assess the significance of BRCA1 variants.

Authors:  Isabelle Cusin; Daniel Teixeira; Monique Zahn-Zabal; Valentine Rech de Laval; Anne Gleizes; Valeria Viassolo; Pierre O Chappuis; Pierre Hutter; Amos Bairoch; Pascale Gaudet
Journal:  Hum Genomics       Date:  2018-07-11       Impact factor: 4.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.